US Stock Lawsuit — What Indian Investors Must
A US law firm is suing Soleno Therapeutics, a NASDAQ-listed pharma company, on behalf of investors who lost money between March and November 2025. This is a foreign securities case with no direct impact on Indian borrowers or RBI rules. Indian retail investors holding US stocks via apps like Vested or INDmoney should stay alert to such risks.
Did you know Indians invested over ₹42,000 crore in US stocks in 2024 alone? That's enough to pay for roughly 210 crore cups of cutting chai — and losses from foreign stock fraud can hit your savings just as hard as a bad loan deal.
If you have money parked in US stocks and those companies face fraud lawsuits, your portfolio value can drop overnight — leaving you scrambling for emergency loans that could cost you 12–24% interest per year.
Key Takeaways
If you invest in US stocks through Indian apps, always research the company's legal history and financial disclosures before putting in money
Diversify your portfolio — do not put more than 10–15% of your savings into a single foreign stock, especially small-cap pharma companies with high volatility
Focus on building a strong credit profile at home — a good CIBIL score above 750 gives you access to lower-interest personal loans when you need emergency funds instead of liquidating risky investments
A US-based investor rights law firm, Rosen Law Firm, has announced a securities class action lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO), a pharmaceutical company listed on the American stock exchange. Investors who purchased Soleno stock between March 26, 2025 and November 4, 2025 have until May 5, 2026 to join the case as lead plaintiffs.
While this case has no direct connection to RBI regulations or Indian lending rules, it is an important reminder for the growing number of Indian middle-class investors who are buying US stocks through platforms like Vested, INDmoney, or Groww. Pharma stocks, especially small-cap ones, carry significant volatility and legal risk that many first-time investors underestimate.
Here is the real-world risk for you: if your US stock investments fall sharply due to fraud or mismanagement, you may suddenly need emergency funds. Personal loans taken in a hurry often come with higher interest rates — sometimes 18–24% per annum — eating deep into your monthly budget. A ₹2 lakh emergency loan at 22% interest means you pay nearly ₹3,700 extra every month compared to a well-planned loan at 12%.
The smarter approach is to keep your finances balanced. Maintain an emergency fund covering 3–6 months of expenses, invest in foreign stocks only with money you can afford to lose, and keep your CIBIL score above 750. A strong credit profile ensures that if you ever need a personal loan, you get the best rate. Apps like GoCredit help you compare personal loan offers from top lenders instantly, so you are never stuck with a bad deal.
Pro Tip: Before investing in any NASDAQ or NYSE-listed stock through an Indian app, search the company name along with 'SEC filing' or 'class action' to check for any ongoing legal trouble. Five minutes of research can save you lakhs.
Compare Loan Offers Now
Open GoCredit App →